Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
Benzinga.com7h
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
Earlier this month, Novavax and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement and an amendment to ...
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NVAX) shares surge 12% as FDA lifts clinical hold on COVID-19-Influenza Combination vaccine candidates.
BioSpace20h
Novavax Shares Slide as FDA Pauses COVID/Flu Vaccine Candidates
Shares of Novavax fell 16% on Wednesday as the FDA placed a clinical hold on its investigational combo COVID-19/influenza and standalone influenza vaccines after a report of a serious adverse event in ...
scmp.com13h
Coronavirus pandemic: All stories
A re-analysis of genomic data previously withheld offers strongest evidence of the natural origin of Covid-19 but doubters, conspiracists and some Western politicians are unlikely to be convinced.